<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01566266</url>
  </required_header>
  <id_info>
    <org_study_id>METC 12-3-011</org_study_id>
    <nct_id>NCT01566266</nct_id>
  </id_info>
  <brief_title>Gut Flora and Lipid Metabolism</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is well known that metabolic responses to diet and drugs are affected by genetic and
      environmental factors. Still, a large part of differences in responses between individuals
      remains unexplained. To increase our understanding of individual differences, more and more
      attention is paid to the role of intestinal microbiota. Not only energy and glucose may be
      related to the microbiota, but also lipid metabolism. This is not surprising as lipid
      metabolism, glucose metabolism, and obesity are closely linked.

      There is substantial evidence from in particular animal studies that the gut microbiota is
      related to lipid and lipoprotein metabolism. However, there is less evidence to what extent
      modulation of the gut microbiota changes lipid and lipoprotein metabolism in humans.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL-cholesterol</measure>
    <time_frame>Measure change between day 1 and day 8</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lipid metabolism</measure>
    <time_frame>Measure change between day 1 and day 8 (HDL-cholesterol, triglycerides)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>Measure change between day 1 and day 8</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">77</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Amoxicillin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo capsules</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <description>2 capsules of 250mg, 3 times per day during 1 week</description>
    <arm_group_label>Amoxicillin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo capsule</intervention_name>
    <description>2 capsules of 250mg, 3 times per day during 1 week</description>
    <arm_group_label>Placebo capsules</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged between 18-70 years

          -  serum total cholesterol: 5-8mmol/L

        Exclusion Criteria:

          -  serum triacylglycerol &gt; 3.0mmol/L

          -  use of oral anticonceptives

          -  pregnant or breastfeeding women

          -  kidney insufficiencies

          -  unstable body weight

          -  allergy to antibiotics

          -  treatment with cholesterol-lowering drugs

          -  use of medication or a medically prescribed diet

          -  active cardiovascular disease

          -  abuse of drugs

          -  more than 21 alcohol consumptions per week for men and 14 consumptions for women

          -  use of an investigational product within the previous 30 days

          -  not willing to stop the consumption of products rich in plant stanol or sterol esters
             3 weeks before start of the study

          -  use of gastric acid inhibitors, laxantia, prebiotica, probiotica and antibiotica for
             at least one month before the start of the study and during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Mensink, Prof. Dr. Ir.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2012</study_first_posted>
  <last_update_submitted>May 13, 2013</last_update_submitted>
  <last_update_submitted_qc>May 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gut flora</keyword>
  <keyword>antibiotics</keyword>
  <keyword>lipid metabolism</keyword>
  <keyword>LDL cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

